Advertisements

Nitroglicerina Doc Generici

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Nitroglicerina Doc Generici

Quick Facts

Property Description
Active Ingredient Nitroglycerin (Glyceryl Trinitrate, GTN)
Pharmacological Class Organic Nitrate Vasodilator, Antianginal Agent
Origin Synthetic Small Molecule
Common Forms Sublingual Tablet, Sublingual Spray, Transdermal Patch
General Purpose To reduce cardiac strain and improve blood flow

What is Nitroglicerina Doc Generici and What Class Does it Belong To?

Nitroglicerina Doc Generici is a generic pharmaceutical preparation containing the active ingredient known as nitroglycerin, which is also chemically identified as glyceryl trinitrate (GTN). This medicine is formally classified within the cardiovascular therapeutic group, specifically known as an Organic Nitrate Vasodilator and Antianginal Agent.

As a generic product offered by the manufacturer DOC Generici, this medication provides the identical qualitative and quantitative composition and therapeutic effect as the original reference drug, ensuring clinical equivalence. Nitroglycerin, the synthetic small molecule active compound, is clinically recognized for its rapid onset of action when administered sublingually. It functions as a prodrug, requiring metabolic conversion within the body to release nitric oxide, which is the key molecule responsible for its primary pharmacological action.


Composition and General Therapeutic Purpose

Nitroglicerina Doc Generici is a single-ingredient product available in several specialized dosage forms, which include the rapidly acting sublingual tablet and sublingual spray, alongside various transdermal preparations like ointments and patches. These forms facilitate sublingual, oral, or transdermal routes of administration, allowing the drug to bypass first-pass metabolism in some cases.

The medication's general therapeutic purpose is to reduce the workload on the heart and assist the circulatory system by promoting vasodilation, the widening of blood vessels. The unique mechanism of nitroglycerin involves acting as a selective venodilator, primarily targeting veins to decrease the volume of blood returning to the heart (known as preload). This overall reduction in cardiac workload defines the medication's essential function: making it easier for the heart to efficiently pump blood, a primary benefit supported by pharmacological studies.

Regulatory References

  1. NIH MedlinePlus Drug Summary for Nitroglycerin
Advertisements

What side effects are possible with Nitroglicerina Doc Generici?

Possible Side Effects and Safety Information

The safety profile of nitroglycerin is primarily defined by the regulatory classification of adverse reactions that arise from its potent vasodilatory action. According to official regulatory documents, adverse effects are grouped by body system and frequency.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects System-Organ Class (SOC)
Very Common Headache (often severe, may subside with continued use) Nervous System
Common Hypotension, Dizziness, Flushing, Tachycardia Vascular, Nervous, Cardiac
Other Syncope, Nausea, Vomiting Various

The most frequent adverse reaction is the dose-related headache. Other documented effects, such as postural hypotension and flushing, are consequences of the drug's effect on the vascular system.

Serious Adverse Reactions and Safety Constraints

Official labeling defines several clinically significant risks. Severe hypotension and syncope (fainting) are documented serious adverse reactions that can occur. A very rare, but serious, concern is methemoglobinemia.

Usage is subject to several absolute restrictions. Nitroglycerin is absolutely contraindicated for use concurrently with Phosphodiesterase Type 5 (PDE5) inhibitors (such as sildenafil) due to the risk of profound and life-threatening drops in blood pressure. The medicine is also restricted in patients with conditions such as marked anemia, acute circulatory failure, or raised intracranial pressure.

Time-Related and Population Safety Notes

Regulatory information notes that tolerance (a diminished effect) may develop with continuous, prolonged exposure, and a drug-free period may be required to maintain effectiveness. Regarding specific groups, older adults may exhibit increased susceptibility to hypotensive effects, though safety in pediatric patients has not been established.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile for Nitroglycerin (Glyceryl Trinitrate, GTN) by detailing the resulting severe clinical manifestations of excessive vasodilation and systemic toxicity.

Documented Overdose Manifestations

An overdose may present with signs of profound vascular dilation, notably severe hypotension (low blood pressure), syncope, vertigo, and a persistent throbbing headache. More severe, life-threatening outcomes documented in regulatory sources include circulatory collapse, coma, seizures, and the metabolic complication Methaemoglobinaemia, which is indicated by cyanosis (bluish discoloration).

Immediate Actions and When to Seek Urgent Help

Seek Immediate Medical Attention or Contact Emergency Services is required for acute, life-threatening symptoms such as collapse, seizure, trouble breathing, or inability to be awakened. Regulatory labeling explicitly states that prompt medical attention must be sought if chest pain persists after a total of three doses administered within a 15-minute period.

Management and Monitoring

Management is defined as Symptomatic and Supportive Treatment. Procedural steps include elevation of the extremities and Central Volume Expansion with Intravenous Fluids to manage hypotension. Regulatory documentation confirms that no specific antidote is known. Continuous monitoring of vital signs (pulse, blood pressure) and mental status is required in a controlled medical setting. Hypotension and syncope are noted as a particular concern in the elderly population.

Advertisements

Therapeutic Uses of Nitroglicerina Doc Generici

What Nitroglicerina Doc Generici Treats: Main Uses and Benefits

Nitroglicerina Doc Generici is commonly used across conditions characterized by periods of heightened symptoms related to cardiovascular strain. The primary therapeutic focus is relevant for easing symptoms associated with acute or episodic changes in the heart’s blood supply, which creates noticeable physiological strain. The medication may be part of symptomatic management for a range of conditions, including angina pectoris, acute heart failure (specifically with pulmonary congestion), and certain hypertensive emergencies when acute cardiac symptoms are present. This medicine is considered relevant for easing symptoms related to physical discomfort, particularly the intense chest pressure or tightness that occurs during an anginal episode. Clinical scenarios often include immediate symptomatic relief, managing symptoms before known triggers (prophylaxis), and providing support in high-acuity settings.

The established use of nitroglycerin for these purposes provides support that helps ease the overall symptom burden, offering symptomatic relief that may assist with maintaining functional stability.

“Generally, this medicine is applied in addressing acute symptomatic distress linked to ischemic events.”


Quick Fact: Relief for Anginal Pain and Cardiovascular Strain

Therapeutic Focus Primary Symptom Addressed Core Patient Benefit
Acute Angina Pectoris Chest pressure and tightness Support in managing acute distress
Prophylaxis (Triggers) Predictable discomfort upon exertion Assists with maintaining functional stability
Acute Stress/Strain Heightened cardiovascular symptoms Contributes to easing the overall symptom load

Regulatory References

  1. NIH DailyMed official FDA labeling
Advertisements

Eligibility and Restrictions for Use

Official Eligibility Profile

The eligibility for using Nitroglicerina Doc Generici (nitroglycerin) is formally defined by regulatory labeling, which outlines patient groups with established safety profiles and those for whom use is strictly prohibited.

Populations Allowed Populations/Conditions Contraindicated (Must Not Use)
Adults for the acute relief or prophylaxis of angina pectoris. Concurrent Use with PDE5 inhibitors (e.g., sildenafil) or sGC stimulators (e.g., riociguat).
Geriatric patients, though caution in dose selection is generally advised. Severe Anemia or conditions causing Increased Intracranial Pressure (e.g., cerebral hemorrhage).

Age-Related Eligibility:

  • Use is established only in adults.
  • Safety and effectiveness have not been established in pediatric patients (children and adolescents) and use is generally not recommended in this population.

Conditional Restrictions:

  • The drug is contraindicated in patients with certain conditions causing obstruction to cardiac outflow, such as Hypertrophic Cardiomyopathy and Aortic Stenosis.
  • Caution is required for patients with pre-existing severe hypotension (e.g., systolic blood pressure <90 mmHg) or acute circulatory failure.

Pregnancy and Lactation:

Limited data are insufficient to determine drug-associated risk during pregnancy. For lactation, it is not known if the drug is present in human milk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Nitroglicerina (Glyceryl Trinitrate) is strictly defined by government regulatory agencies and centers on specific prohibited combinations and pharmacodynamic effects.


Prohibited Combinations (Absolute Contraindication)

Co-administration of nitroglycerin with the following drug classes is absolutely contraindicated due to the high risk of severe, life-threatening hypotension:

  • Phosphodiesterase Type 5 (PDE-5) Inhibitors (e.g., Sildenafil, Tadalafil, Vardenafil).
  • Soluble Guanylate Cyclase (sGC) Stimulators (e.g., Riociguat).

Pharmacodynamic and Exposure Interactions

Interacting Substance/Class Official Interaction Description
Antihypertensive Medicines (e.g., Beta-blockers, Calcium Channel Blockers) Additive hypotensive effect (lowering of blood pressure)
Heparin (Intravenous) Reduced anticoagulant effect; requires close monitoring
Alteplase (Intravenous) Reduced thrombolytic effect
Dihydroergotamine (Oral) Increased oral bioavailability of dihydroergotamine due to reduced first-pass metabolism
Alcohol (Ethanol) Additive hypotensive effect

Time-Separation Constraints

If the administration of nitrates is medically necessary following the use of a PDE-5 inhibitor, specific minimum separation windows are required:

  • Tadalafil: Wait at least 48 hours.
  • Sildenafil/Vardenafil: Wait at least 24 hours.

This information is based exclusively on official regulatory labeling to describe documented pharmaceutical constraints.

Advertisements

Mechanism of Action

The pharmacological effect of Nitroglicerina Doc Generici is defined by a precise biochemical cascade that converts the drug into an active cellular signaling agent, resulting in vascular relaxation and reduced cardiac load.


Bioactivation and Nitric Oxide (NO) Signaling Cascade

The active ingredient, Nitroglycerin (GTN), functions as a prodrug that must be converted by the mitochondrial enzyme Aldehyde dehydrogenase 2 (ALDH2) to release Nitric Oxide (NO). This NO molecule is the key signaling molecule that binds to and activates the enzyme soluble Guanylate Cyclase (sGC), initiating the cGMP signaling pathway—a fundamental sequence for controlling smooth muscle activity.


Smooth Muscle Relaxation and Hemodynamic Load Adjustment

The activation of the cGMP pathway results in a cellular cascade that causes the final relaxation of vascular smooth muscle (vasodilation) by decreasing the cells' ability to contract. This widening is preferential toward the large capacitance veins, increasing venous capacity and causing blood to pool peripherally. This systemic adjustment reduces the volume and pressure of blood returning to the heart (preload), which decreases cardiac wall tension and the myocardial oxygen consumption ( MVO2).


Mechanistic Limits: Tolerance and Pathway Interference

The effectiveness of this mechanism can be limited by the availability and function of the ALDH2 enzyme, which can become desensitized or depleted with continuous exposure, a process underlying nitrate tolerance. Furthermore, the cGMP signaling pathway can be critically influenced by other agents, such as Phosphodiesterase 5 (PDE5) inhibitors, which block the breakdown of cGMP and lead to an exaggerated, excessive vasodilatory effect.

Advertisements

Dosage and Administration Information

How to Use Nitroglicerina Doc Generici

Nitroglycerin is administered via several distinct routes to achieve either rapid or sustained pharmacological action. The choice of form—such as sublingual (under the tongue), transdermal (through the skin), or intravenous (IV)—dictates the appropriate use pattern and setting.

Dosing and Frequency Patterns

For acute symptoms, the standard dosing regimen for sublingual or oromucosal spray forms is one dose (e.g., 0.3 mg to 0.6 mg tablet or 400 mcg spray) at the onset of symptoms while the patient is at rest. This dose may be repeated approximately every 5 minutes, but the total administration must not exceed three doses within a 15-minute period.

For maintenance therapy using long-acting forms like the transdermal patch, the administration is typically once daily and requires a nitrate-free interval of 10 to 12 hours. This intermittent cycling is an administration requirement to prevent the development of pharmacological tolerance, ensuring sustained effectiveness over time.

Administration Specifics

Sublingual doses must be placed directly under the tongue or in the buccal pouch and allowed to dissolve; they should not be swallowed. When administering the spray, it must be directed onto or under the tongue without being inhaled. For intravenous use in controlled clinical settings, the concentrate must be diluted in compatible solutions (e.g., 5% Dextrose) and administered using a controlled infusion device.

Population Considerations

Instructions specify that dose selection for older adults should be cautious, often starting at the lower end of the dosing range. Use in pediatric patients is generally not recommended as safety and efficacy have not been established.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nitroglicerina Doc Generici

Research examined the active ingredient nitroglycerin in the context of symptom patterns related to specific cardiovascular conditions. The available evidence comes mainly from controlled clinical trials and large observational studies.


Research Evidence for Acute Angina Symptom Relief

Research examined short-acting forms for stable angina using Randomized Controlled Trials (RCTs). These trials explored short-term episodic symptom patterns, focusing on outcomes related to physical discomfort like the time interval to symptom change, and functional measures like exercise tolerance. Studies report how symptoms evolved often describing changes in acute physical discomfort within minutes. However, existing studies provide limited insight into long-term health outcomes, and research highlights a documented pattern of tolerance—meaning the effect may lessen over time—with continuous use.


Research Evidence for Acute Cardiovascular Strain

Research examined use in conditions associated with acute or disruptive episodes, such as acute decompensated heart failure (ADHF) with high blood pressure, utilizing smaller RCTs and large retrospective cohort studies. These studies explored physiological strain and short-term clinical metrics. The findings varied across studies; some described patterns related to data showing lower rates of acute interventions in specific subgroups, but overall data show patterns related to an inconsistent impact on short-term functional status. Certainty remains low for generalized effects.


Long-Term Studies and Evidence Gaps

The research landscape has primarily focused on episodes where symptoms become more noticeable and on short-term symptom patterns. Follow-up durations were limited in many core trials, and long-term effects are not fully established regarding the durability of response or the evaluation for influencing long-term condition progression. The majority of pivotal studies was evaluated in adults, including older adults. Data for certain groups, such as children, pregnant women, or those with specific comorbidities, remain insufficient, reflecting that the results apply only to the populations studied. Research is ongoing to better define its long-term impact, as evidence quality varies across studies.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nitroglicerina Doc Generici (FAQ)


Q: Does Nitroglicerina Doc Generici help prevent future heart problems or just treat immediate symptoms?

A: Nitroglycerin is officially indicated for the acute relief and prophylaxis of episodic chest pain (angina pectoris). According to regulatory documents, the medication primarily works to reduce symptoms and cardiac strain during an event. Official labeling focuses on short-term symptom management, not generally on preventing long-term cardiovascular disease progression.


Q: Can taking Tylenol (paracetamol) affect how Nitroglicerina Doc Generici works?

A: Specific interactions between nitroglycerin and acetaminophen (Tylenol or paracetamol) are not commonly noted in the official product labeling. However, consultation with a healthcare professional is important when combining any medications, as some other common medicines, like aspirin, may have documented interactions.


Q: What happens if I accidentally swallow the spray instead of holding it under your tongue?

A: The sublingual (under the tongue) forms are specifically designed to be absorbed rapidly through the lining of the mouth. Official product information advises against swallowing the medication, as this may lead to less effective absorption and could result in reduced or delayed relief from your symptoms.


Q: Can I keep my Nitroglicerina Doc Generici bottle in my pocket or purse?

A: Nitroglycerin should be stored at a controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). The product can be briefly exposed to temperatures up to 30 C when transporting it. To help maintain effectiveness, it is important to protect the container from excessive heat, cold, and moisture.


Q: What should I avoid doing right after I use my nitroglycerin spray?

A: The medication can cause the blood vessels to widen, potentially leading to dizziness and low blood pressure (hypotension). Due to this potential effect, official information suggests resting in a seated or lying position during and immediately after use to help prevent falls.


Q: Is Nitroglicerina Doc Generici safe for people who also take blood thinners?

A: Official labeling notes a documented interaction with intravenous Heparin, where the anticoagulant effect may be reduced. When combining this medication with any medicine that affects the cardiovascular system, consultation with a healthcare professional is important to ensure safety and effectiveness.


Q: Can people with asthma or other breathing problems use this medication?

A: In official product information, no specific general contraindications related to asthma or common breathing problems are listed. However, the drug is contraindicated for severe anemia and any condition causing increased pressure in the head (intracranial pressure).


Q: How is the potency of Nitroglicerina Doc Generici measured compared to other nitroglycerin products?

A: The potency of the spray is measured precisely by the manufacturer and is stated on the label in milligrams (mg) or micrograms (mug), indicating the exact amount of active ingredient dispensed per dose. Although some users may feel a tingling or burning sensation under the tongue, official labeling states this sensation is not a reliable way to determine the drug's potency or activity.


Q: Is Nitroglicerina Doc Generici only used for angina or are there other common uses?

A: The product is officially indicated for the relief and acute prevention of angina pectoris (chest pain). It may also be used in controlled hospital settings to treat other acute cardiovascular conditions, such as acute heart failure when accompanied by high blood pressure.


Q: Can the heat or cold outside affect the medication's effectiveness?

A: Yes, official storage requirements advise that the product must be protected from excessive heat and moisture. Exposure to temperatures outside the recommended range for long periods can cause the medication to degrade, potentially compromising its potency and effectiveness when needed.


Q: Are there specific over-the-counter medicines that are dangerous to mix with nitroglycerin?

A: The most serious contraindication is the combination with certain prescription PDE-5 inhibitors used for erectile dysfunction. Outside of this, labeling advises caution with any over-the-counter medicines, supplements, or alcohol that could also cause a drop in blood pressure, as the effects would be additive (combined), potentially leading to severe low blood pressure.


Q: What kind of research has been done on the safety of Nitroglicerina Doc Generici for women?

A: Official information states that safety data during pregnancy and lactation is limited or insufficient. The decision regarding use during pregnancy or lactation should be made by a healthcare professional after carefully weighing the potential benefits and risks.


Q: If I feel a tingling or burning sensation under my tongue, is that a sign the spray is working?

A: A tingling or burning sensation is a known side effect that may occur when the medicine is administered sublingually. However, according to patient information and regulatory documents, this sensation should not be relied upon as a definite sign that the drug is potent or actively working.


Q: What's the typical shelf life of an unopened bottle of Nitroglicerina Doc Generici?

A: The medication's total shelf life is determined by the manufacturer and marked by the expiration date on the packaging. Because the active ingredient can be volatile, certain forms may have specific instructions regarding disposal after they are opened.


Q: Can using too much nitroglycerin make my chest pain worse?

A: An overdose of nitroglycerin can lead to severe side effects related to profound drops in blood pressure (hypotension) and fainting (syncope). Overdose symptoms can include these severe drops in blood pressure and, rarely, can be accompanied by an increase in chest discomfort.


Q: What type of doctor usually prescribes Nitroglicerina Doc Generici?

A: The medication is indicated for the treatment of angina pectoris, a condition managed by healthcare professionals specializing in cardiovascular care. It is commonly prescribed by cardiologists or general practitioners who manage heart conditions.


Q: How long after a cardiac event is it typical for patients to start using this medication?

A: Nitroglycerin is used to treat or prevent acute angina attacks that arise from heart disease. Its use in the period following a cardiac event (like a heart attack) is often managed under specific clinical guidelines and may require continuous monitoring by medical staff.


Q: Can I use the spray if I have dentures or other dental work?

A: The drug is administered onto or under the tongue for rapid absorption through the oral mucosa. Dentures or other dental work should not generally interfere with the medicine's effectiveness, provided the spray makes direct contact with the tissue in the mouth as instructed.


Q: What should I do if the spray bottle doesn't seem to be working or dispensing correctly?

A: Official patient information often includes instructions for checking the volume of medication. If the spray does not dispense correctly, the container should be replaced to help ensure the proper dose is available during an episode.


Q: Can people with glaucoma use Nitroglicerina Doc Generici?

A: Product labeling advises caution when using the drug in patients with conditions that cause increased intracranial pressure (pressure inside the head). Any use when managing glaucoma should be discussed with a healthcare professional.


Q: Are there any known long-term effects of using nitroglycerin regularly for many years?

A: Clinical trials often have limited follow-up periods, and the long-term effects of using nitroglycerin regularly for many years are not fully established in official research. Documented risks with continuous, high exposure include the development of pharmacological tolerance, which reduces the drug's effectiveness over time.


Q: Can a person become dependent on the feeling of relief from the spray?

A: Physical dependence on organic nitrates has primarily been documented in non-clinical settings, such as industrial exposure. While this phenomenon is known, official product information does not generally focus on dependence in typical patient use.


Q: What does Nitroglicerina Doc Generici look like, and how is the spray dispensed?

A: Nitroglicerina Doc Generici is supplied in a container that dispenses the medicine as a metered-dose liquid spray. It is designed to be administered with a specific volume of the drug being sprayed onto or under the tongue.


Q: How quickly should I expect to feel the effect after taking a dose of nitroglycerin?

A: The sublingual (under the tongue) form is designed for rapid symptom relief. Clinical studies and product information indicate that patients should typically begin to feel a change in acute chest discomfort within minutes of administration.


Q: How long does the effect of one dose of the spray typically last?

A: Nitroglycerin is a short-acting drug used for acute relief. Product information indicates that if symptoms persist, a dose may be repeated after approximately five minutes, suggesting the rapid effect of a single dose is short-lived.


Q: Does consistent use of nitroglycerin lead to the body building up a tolerance?

A: Yes. Official warnings indicate that when nitroglycerin is used continuously for prolonged periods, the body may develop tolerance, meaning the drug may lose effectiveness. To help maintain its desired action, long-acting forms often require a daily 'nitrate-free interval' to restore sensitivity.


Q: Why do doctors recommend being seated or lying down when using the spray?

A: Because the medication works by widening blood vessels, a common side effect is a rapid drop in blood pressure (hypotension) that can cause dizziness or fainting (syncope). Resting in a seated or lying down position during use helps reduce the risk of injury if this blood pressure drop occurs.


Q: Is it normal to feel dizzy or lightheaded right after using the spray?

A: Feeling dizzy or lightheaded is listed as a common side effect in the official product information. These effects are a direct consequence of the drug's action of lowering blood pressure, which is central to how it works.


Q: What happens in the body when someone experiences nitrate tolerance?

A: Nitrate tolerance is a biological process where the body's systems become less sensitive to the drug. According to the mechanism of action, this is thought to be due to changes in the enzyme that converts nitroglycerin into its active form, nitric oxide, causing the drug to stop working as effectively.


Q: Are there any common foods or drinks that interact with this medication?

A: Official labeling specifically notes that alcohol (ethanol) can have an additive effect, leading to excessive drops in blood pressure (hypotension). Otherwise, no specific common foods or non-alcoholic beverages are typically listed as having a direct and significant interaction.


Q: What are some less common but important side effects that users report?

A: In addition to the very common headaches and dizziness, other documented side effects include nausea, vomiting, and fainting (syncope). Serious adverse reactions can include severe drops in blood pressure and a rare, but serious, condition called methemoglobinemia.


Advertisements

How should Nitroglicerina Doc Generici be stored and disposed of?

Nitroglycerin products must be stored correctly to maintain potency, as the active substance is volatile and sensitive to degradation.

Storage Requirements

Condition Recommendation
Temperature Keep at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). Avoid excessive heat or freezing.
Container Sublingual tablets should be kept in their original glass container with the cap tightly closed after each use.
Environment Protect from light, heat, and moisture. Do not store in the bathroom or in a car where temperatures can fluctuate widely.

Disposal Guidelines

Discard any expired or unused medication according to local and national regulations. Do not flush nitroglycerin down the toilet or pour it down a drain unless specifically instructed to do so by a drug take-back program or a healthcare professional. Consult your pharmacist or local waste disposal agency for information on approved disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nitroglicerina Doc Generici found in:

A-Z Index: